Though the report's sample size is fairly small, it does offer hope during a challenging time for cardiologists. 

Hospitalizations are also getting shorter, allowing patients to return to the comfort of home earlier than before. 

Eric Stecker, MD, chair of the American College of Cardiology's Science and Quality Committee, joined us for an exclusive interview. 

Access to endovascular therapy does not appear to be the issue. 

As one might expect, the largest economic burden linked to HF is related to hospitalizations.

The new guideline calls for a “stepwise approach," followed by close clinical surveillance, when treating uncomplicated TBAD. In some cases, however, earlier endovascular treatments may be necessary. 

All patients included in the analysis faced a high risk of complications, researchers noted.